Myomo (MYO) Stock Price

Myomo Price

NYSE AMEX·CLOSED
1.45
​
Market closed

Revenue has compounded at 41.3% per year over the past 11 years to 40.93 M USD. Myomo's net margin stands at -38.1%, up from -74.9% several years earlier. Analysts set a median price target of 4.08 USD, implying 181.4% above the current price. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Myomo stock price

Access this data via the Eulerpool API

Myomo business model & stock analysis

Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2017-06-12. The firm offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The firm develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. The company primarily provides devices directly to patients and bills their insurance companies.

Frequently asked questions about Myomo

Analysts currently set an average price target of 5.10 USD for the Myomo stock (median: 4.08 USD), implying +251.7 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Myomo stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Myomo to generate revenue of 45.60 M USD and earnings per share of -0.28 USD.

Converted at the current exchange rate, the Myomo share trades at 1.29 EUR (1.45 USD).

The Myomo share (MYO) is listed on 2 stock exchanges, including: Frankfurt (0M61.F).

The expected revenue of Myomo is 45.60 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Myomo is -11.79 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Myomo is currently -5.15. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Myomo stock.

The price-to-sales ratio (P/S) of Myomo is currently 1.33. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Myomo stock.

The Eulerpool Quality Score for Myomo is 4/10.

The ISIN of Myomo is US62857J2015. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Myomo is A2PZCL. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Myomo is MYO. The ticker symbol is used to trade Myomo shares on the stock exchange.

Fair ValueTerminal
1.26 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
409,280.43 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website myomo.com
Currency
USD
Initial public offering
Jun 12, 2017
ISIN
US62857J2015
Cusip
62857J201
Market capitalization
55.74 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-5.15
P/Ee 2027
-7.18
P/Ee 2028
-8.77
P/Ee 2029
72.50
P/Ee 2030
5.58
P/S
P/Se
1.33
EV/EBIT
—
P/B Ratio
4.89
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-50.59 %
Last updated Oct 9, 2026, 3:38 AM

Myomo Peer Group

Myomo Ticker

AMEX · MYOFRANKFURT · 0M61.F

Myomo FIGI

MYO:US · BBG002B0JJV6MYO:UA · BBG00G71YZX3MYO:UN · BBG00G71YZZ1MYO:UP · BBG00G71Z005MYO:UB · BBG00G71Z023MYO:UT · BBG00G71Z032MYO:UM · BBG00G71Z041MYO:UX · BBG00G71Z050MYO:UD · BBG00G71Z0B3MYO:UF · BBG00G71Z0F9MYO:VY · BBG00G71Z0G8MYO:VJ · BBG00G71Z0H7

All fundamentals and in-depth analysis of Myomo

Our stock analysis for Myomo stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Myomo. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.